Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Future Healthcare Journal

  • FHJ Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About FHJ
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Future Healthcare Journal

futurehosp Logo
  • FHJ Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About FHJ
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

The ‘CURE IT’ programme – introducing equity, removing barriers, and treating patients with hepatitis C close to home: the Queensland experience

Hayley Thompson, Tony Rhaman and Myat Lin Lei
Download PDF
DOI: https://doi.org/10.7861/fhj.7.1.s16
Future Healthc J February 2020
Hayley Thompson
AThe Prince Charles Hospital, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tony Rhaman
AThe Prince Charles Hospital, Brisbane, Queensland, Australia
BUniversity of Queensland, Brisbane, Australia, and James Cook University, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myat Lin Lei
AThe Prince Charles Hospital, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Background and aims

Healthcare delivery in Queensland has geographical challenges including distance, transport and distribution of specialists and services. Hepatitis C virus (HCV) affects approximately 230,000 people in Australia. In 2016, the Pharmaceutical Benefits Scheme facilitated primary care prescribing of the new direct-acting antivirals (DAAs). Traditional HCV treatment occurred in tertiary hospitals, requiring patient travel, multiple attendances and missed appointments.

The ‘CURE IT’ programme facilitates a shared model of care between community prescribers and hospital specialists, while providing clinical, financial and a best practice governance encouraging appropriate treatments. The ‘CURE IT’ programme is ‘echo-lite’, utilising a clinical nurse and hospital consultant offering daily advice to municipal, regional and remote communities, needle exchange workers and hospital prescribers. All patient treatments are facilitated by the treating general practitioner (GP) close to home. Patients with advanced liver disease were referred before or after treatments.

Method

From March 2016 all referrals to the Prince Charles Hospital were reviewed for suitability for CURE-IT. Simultaneously, community providers were engaged and provided with written and verbal education regarding HCV treatment and the CURE IT programme. Completed pro formas containing relevant information (patient demographics, medical history, ultrasound and laboratory results) were returned to the specialist, whereupon, following review, patients were commenced on treatment in 1–2 business days. The average time taken for the specialist to review each request was 5–7 minutes.

Results

Between March 2016 and November 2018, 380 remote treatment requests were assessed:

  • 371/380 (97.6%) patients approved for community-based treatment.

  • 350/380 (92.10%) patients, GP commenced DAA therapy

  • 371/380 (97.63%) patients avoided hospital visits

  • 9/380 (2.37%) patients referred for specialist review

  • 220/350 (62.85%) patients completed therapy

  • 218/220 (99%) patients achieved sustained virologic response (SVR)

  • 38/380 (10%) patients lived 70–647 km from Brisbane

    • 1,200–1,600 outpatient appointments avoided

    • >44,000 km of travel avoided.

Conclusion

CURE-IT has redefined specialist healthcare delivery achieving SVR in 99% of patients, not one of whom have attended hospital. Other endpoints have resulted in a ‘patient-centred, patient-focused programme’ of factors most important to patients – treatment closer to home, treatment by a trusted GP, reduction of hospital visits, reduction in time lost from work, reduction in financial loss for patients and distance travelled by patients, and this may all be doubled if partners also attended. The CURE IT programme has also had unintentional network gains including: dynamic collaborative relationships with primary care; increased awareness of HCV, liver disease, cirrhosis, liver cancer and treatments, leading to upskilling of regional and rural healthcare workers.

Conflicts of interest

None declared.

  • © Royal College of Physicians 2020. All rights reserved.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The ‘CURE IT’ programme – introducing equity, removing barriers, and treating patients with hepatitis C close to home: the Queensland experience
Hayley Thompson, Tony Rhaman, Myat Lin Lei
Future Healthc J Feb 2020, 7 (Suppl 1) s16; DOI: 10.7861/fhj.7.1.s16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The ‘CURE IT’ programme – introducing equity, removing barriers, and treating patients with hepatitis C close to home: the Queensland experience
Hayley Thompson, Tony Rhaman, Myat Lin Lei
Future Healthc J Feb 2020, 7 (Suppl 1) s16; DOI: 10.7861/fhj.7.1.s16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Background and aims
    • Method
    • Results
    • Conclusion
    • Conflicts of interest
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Fracture Liaison Services in England and Wales, inequity of access and quality of care after a fragility fracture
  • The end of weak handover
  • Developing service delivery guidelines on acute medical emergencies: challenges and solutions
Show more Health Services and Policy

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home

Other Services

  • Advertising
futurehosp Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians